STF-Study tagging file

Slides:



Advertisements
Similar presentations
Design Validation CSCI 5801: Software Engineering.
Advertisements

The Importance of CDASH
Review Writing XML  Style  Common errors 1XML Technologies David Raponi.
XML CS 105. What is XML? XML stands for Extensible Markup Language. XML is a markup language like HTML. XML was designed to describe data. You must define.
Preclearance Procedure & Operations Helpful pointers about the submission process 1 Dannie Newman PAAB Reviewer
©2014 Factorytalk Co., Ltd. Proprietary and Confidential eCTD Specification 17 July 2014.
Adding metadata to intranet documents Please note: this is a temporary test document for use in internal testing only.
Assessing Quality-by-Design A CMC Review Perspective
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
CDER IND/NDA Reviews Guidance, The Common Technical Document and Good Review Practice John K. Leighton, Ph.D., DABT CDER/FDA.
XML, DITA and Content Repurposing By France Baril.
1 SPL Technology Presentation The Technology of Structured Product Labeling Presented by Robert H. Wallace 06 June 2004.
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
Justina A. Molzon, MS Pharm, JD
BY Karen Liu, Ph. D. Indiana State University August 18,
eCTD: Module 1 from submission to reviewer
Moodle (Course Management Systems). Assignments 1 Assignments are a refreshingly simple method for collecting student work. They are a simple and flexible.
New Semantic Elements (Part 3). The Element The official specification for states that it “represents the heading of a section. The element is used to.
Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.
IRISS Lifecycle Group Joe Cipollina – Pfizer Ted Hanebach – canreg Shy Kumar – Datafarm Inc. Alastair Nixon – GlaxoSmithKline Kevin Wing - eCTDConsultancy.
Nickelodeon – Blogs User Guide. 1. Introduction The admin tool allows you to create and publish blog posts easily and efficiently along with managing.
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
J. B. Chemicals & Pharmaceuticals Ltd. © Copyright 2005 J. B. Chemicals Pharma Ltd. Electronic Submissions – eCTD Advantages Dr Milind Joshi.
Lecture 16 Introduction to XML Boriana Koleva Room: C54
XRX Basic CRUDS Create, Read, Update and Delete and Search XML Data Date: May 2011 Dan McCreary President Dan McCreary & Associates
HTML Basics. HTML Coding HTML Hypertext markup language The code used to create web pages.
FDA ICH Public Meeting 5630 Fishers Lane, Rockville, MD May 8, :30 am -- 2:00 pm Implementation of the CTD Update-Issues-Next Steps Justina A. Molzon,
HEI/OCAN College Access Program Data Submissions.
1 COMMON TECHNICAL DOCUMENT / ORIGIN OF CTD… ICH EWG CTD WAS OFFICIALLY SIGNED OFF IN NOVEMBER 2000, AT 5 TH ICH CONFERENCE; SAN DIEGO,CALIFORNIA.
BioUtah Pre-Submission Issues Workshop April 6, 2016 Ryan O’Callaghan Phil Triolo and Associates LC.
Text2PTO: Modernizing Patent Application Filing A Proposal for Submitting Text Applications to the USPTO.
Exercise # 1 Access the SM All Items View Grid / Determine how Many Dairy Items there are? 1.Go to Supplier Monitor Tab 2.In the “Select an Item” box,
Regulation of Generic Animal Drugs in the United States
An Overview of eCTD for CMC Specialists Dr Martin Moxham June 2010 iRegulatory Ltd, 1 Viewpoint Office Village, Babbage Road, Stevenage, SG1 2EQ, United.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
Validation Gary Gensinger Deputy Director Office of Business Process Support Center for Drug Evaluation and Research.
Search Engine Optimization
HTML Basics.
Always Check Content before Submission on Online Platforms One of the most important tips before submitting any online post is to check the content.
eCTD: Module 1 from submission to reviewer
Section 4.1 Section 4.2 Format HTML tags Identify HTML guidelines
Your Name Proposal Creation Module 5 Your Name
Validation.
CTD Content Management
Requirements Analysis Scenes
eCTD Lifecycle Gary M Gensinger
Creating Accessible PDFs from Word Docs
OpenStorage API part II
Handling ongoing variations concerning same document
Welcome to: eCTD Hands-on Workshop
Validation.
Study Tagging File Workshop
JSS College of Pharmacy Ooty, Tamil Nadu Sunday, April 24th , 2016
MODULE 7 Microsoft Access 2010
Labeling and Electronic Initiatives
New PowerPoint Template
EU SUBMISSION BY Haripriya & Revathy.
[insert Module title here]
Module 5: Data Cleaning and Building Reports
New PowerPoint Template
[insert Module title here]
Business Cases and Advantages of eCTD v4.0
Fundamentals of Electronic Submissions and eCTD
Business View on eCTD v4.0 Advantages and challenges when considering implementation to overcome constrains of the current eCTD specification.
[insert Module title here]
Introduction to HTML5.
Introduction to the ISB Intranet
Metadata Typical metadata requested about a pdf during the ETD submission process: Most ETD submission processes.
Adobe Acrobat DC Accessibility - Metadata, Reading Order, Links
5.00 Apply procedures to organize content by using Dreamweaver. (22%)
Presentation transcript:

STF-Study tagging file Study Tagging Files contain descriptive information on nonclinical and clinical studies in Modules 4 and 5. In FDA- It is used. for EU-not applicable and for CA- It can be used but optional.

Need for STF The eCTD is amazing because it allows reviewers to find the same information in the same place for any type of application. E.g.: cover letter is always under section 1.2 Confusion of a reviewer searching for case report forms for a particular study who, instead of finding them in their assigned spot, locates them scattered all throughout Module 4 0r 5.

Satisfying needs = Role of the STF Organizes study information into meaningful , standardized headings . Provides capability to group documents in a logical order Allows reviewer to quickly understand what has been submitted, what has not. Helps guide reviewer to specific documents they are looking for. Provides consistency over the lifecycle of the regulatory application.

Good Representation of STF in M5

Bad Representation of STF in M5

Understanding the STF and its correct usage is “vital”. when the STF is not used, the submission in many cases, pass technical validation. The review team, as it examines the submission- entity detecting the errors – in review tool display. The simple solution is always to use an STF when you are submitting any type of study file. Always take the time to construct the appropriate STF file, apply the correct tags and make sure your leaf titles are succinct and meaningful—that is, they tell the reader what the file is in as few words as possible.

STUDY-IDENTIFIER ELEMENT Title Element - Title of the study, not the title of each individual document. study-id Element – It is the internal alphanumeric code used by the sponsor to unambiguously identify this study. Category Element - Additional level of study organization not currently provided by the eCTD DTD. This element is only relevant for studies provided in the specific CTD sections cited below. 1) Single dose toxicity (grouped by species and route of administration) 2) Repeat dose toxicity (grouped by species, route of administration, and duration if applicable) 3) Long term [carcinogenicity] studies (grouped by species) 4) Study reports of controlled clinical studies pertinent to the claimed indication (grouped by type of control)

STUDY-DOCUMENT AND DOC-CONTENT ELEMENTS Property element -The property element is appropriate when files might need to be grouped by an applicant provided value. Currently, this element should only be used for site identification within a study. For example, [us] site-identifier 2 ( [i.e] info-type="us" ; name="site-identifier“ ) File-tag element - The file-tag element contains the attributes name and info-type . For example, [ich ] Study report body ( [i.e] info-type ; name)

ASASSSSAsaanmxMNXBgenda Creating STF Files STF (Study Tagging Files) Created under M5.3.1 Section ASASSSSAsaanmxMNXBgenda

ASASSSSAsaanmxMNXBgenda SAS in eCTD SAS files are added along with the other clinical documents ASASSSSAsaanmxMNXBgenda

Example: STF in XMl view

LCM The Study name of the stf will be always APPEND when making any changes. The Stf files under the study category will have New, Replace and Append Doc operations to be performed. We cannot perform continues append in sequences. When the original document is deleted, any appended documents must be deleted. So Operations to the sequence of appended document will fail.

When to use replace vs. append Don’t use append to replace things For incremental appends – instead use replace Safety reports – follow-up to initial safety report – use replace draft labels – use replace, not append Replace doesn’t mean “mistake” . Use append when you are adding a little more information to an existing document, not resubmitting all the same info, plus a little more

Changes to STF Study Document Information Adding New Files to an Existing STF – use append . Deleting Files Cited by an Existing STF - use delete operation so leaf element for the file will be flagged as deleted. Correcting File-tag Values : “Replace" the incorrectly tagged leaf element and use Replace operation to create a new file with tag values changed.

ASASSSSAsaanmxMNXBgenda SAS files in Module 2 Clinical Efficacy and Clinical Safety SAS files will also be added in M2.7.3 and M2.7.4 ASASSSSAsaanmxMNXBgenda

Example : Issue Problem: You placed a pivotal study under 5.3.1.1, and now you realize it needs to be under 5.3.5.1 Solution: Delete out all the leaf IDs that were referenced in the STF under the wrong heading element. This deletes the STF. Create a new STF referencing all the same files, but use new leaf IDs and Submit in new submission sequence.

5.3.7 and 5.3.5.4 FDA does not use 5.3.7 for CRFs Reviewers can’t tell which CRFs go to a study Instead, CRFs should be referenced in each study’s STF and tagged “case report form” ---------------- Create an STF, under 5.3.5.4 – call it “Non-IND Safety Reports” Safety reports related to the drug but not that specific IND

References http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM204900.pdf http://estri.ich.org/STF/STFV2-6-1.pdf http://www.raps.org/personifyebusiness/Portals/0/Documents/focus_june10_tagging.pdf